Year: 2024

Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE

CORAL GABLES, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company...

IRLAB to Present Clinical and Preclinical Data at the AD/PD(TM) 2024: 18th International Conference on Alzheimer’s & Parkinson’s Diseases

GOTHENBURG, SWEDEN / ACCESSWIRE / February 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2024 - IRLAB Therapeutics...

Zeto Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance

HITRUST Risk-Based, 2-year (r2) Certification validates Zeto is committed to strong cybersecurity and protecting sensitive dataSANTA CLARA, CA / ACCESSWIRE...

Global Clinical Alarm Management Market Analysis/Forecast Report 2023-2028: Gradual Shift of Accountability from Payers to Providers and Growing Demand for Value-Based Healthcare

DUBLIN, Feb. 26, 2024 /PRNewswire/ -- The "Global Clinical Alarm Management Market by Product (Nurse Call Systems; Connectivity/Integration Software -...

ConcertAI’s TeraRecon Launches Three New Care Suites, Life Sciences Platform, and Strategic Partnerships at #ECR24

New Clinical AI care suites for Cardiology, Pulmonology, and Neurology; First-in-Class multi-modal predictive and Gen AI platform for research and...

error: Content is protected !!